Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Postgrad Med J ; 91(1073): 151-62, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-25681385

RESUMO

Recurrent miscarriage is frustrating for the physician and a heartbreaking experience for the patient. Approximately 5% of couples trying to conceive have two consecutive miscarriages. Despite a thorough study of patients, the aetiology of this common obstetric complication is unknown in 50% of cases. Known causes include abnormal chromosomes, endocrinological disorders and uterine abnormalities. Although antiphospholipid antibodies have been demonstrated in miscarriages, the role played by alloimmune mechanisms remains unclear. New immunological approaches such as natural killer cells, regulatory T cells, tumour necrosis factor α, cell-derived microparticles, leptin, certain glycoproteins and cytokines should be considered. The management of thyroid diseases and immunological disorders is continuously evolving. Several genetic diagnostic procedures such as parental karyotyping and preimplantation genetic screening should probably not be used routinely. Antiphopholipid syndrome and some recurrent miscarriage-related endocrinological disorders can be effectively treated. Finally, new therapeutic approaches and the pleiotropic effects of old ones have led to improved fetal-maternal outcomes.


Assuntos
Aborto Habitual/prevenção & controle , Anticorpos Antifosfolipídeos/administração & dosagem , Fator Estimulador de Colônias de Granulócitos/administração & dosagem , Fatores Imunológicos/administração & dosagem , Complicações Hematológicas na Gravidez/terapia , Anormalidades Urogenitais/terapia , Útero/anormalidades , Aborto Habitual/etiologia , Aborto Habitual/terapia , Feminino , Aconselhamento Genético , Humanos , Imunoterapia , Gravidez , Complicações Hematológicas na Gravidez/imunologia , Medicina Reprodutiva , Anormalidades Urogenitais/complicações , Anormalidades Urogenitais/imunologia , Útero/imunologia
2.
J Urol ; 162(1): 177-81, 1999 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-10379783

RESUMO

PURPOSE: Although the prepubertal immune system cannot recognize postmeiotic germ cell antigens, an overall 21 to 28% incidence of antisperm antibodies directed at these antigens has been reported preoperatively in prepubertal children with cryptorchidism and other inguinoscrotal anomalies. We investigated the prevalence of antisperm antibodies in these prepubertal patients before and after surgery. MATERIALS AND METHODS: We examined 82 prepubertal boys 0.6 to 13.2 years old, including 33 with unilateral cryptorchidism, 21 with inguinoscrotal anomalies and 28 who were normal. IgG, IgM and IgA antisperm antibodies were determined by the indirect Immunobead test. Serum testing was repeated 1 and 2 years postoperatively and annually for 2 more years in the normal children. Also sera from 183 infertile men 21 to 47 years old with a history of cryptorchidism and/or inguinal hernia operated on in childhood were similarly studied. RESULTS: Of the adults 70 (39%) tested IgG positive, including 12 (7%) who were also IgA positive, and all tested IgM negative. Repeat measurements were negative for all IgG, IgA and IgM isotypes in all children, patients and controls. CONCLUSIONS: We conclude that there are no antibodies to sperm surface antigens in prepubertal children with cryptorchidism and inguinoscrotal anomalies before and within 2 years after surgery. Autoimmunity against postmeiotic sperm membrane antigens is apparent in adults only.


Assuntos
Autoanticorpos/sangue , Criptorquidismo/sangue , Espermatozoides/imunologia , Adolescente , Criança , Pré-Escolar , Criptorquidismo/imunologia , Humanos , Lactente , Masculino , Período Pós-Operatório , Cuidados Pré-Operatórios , Puberdade , Anormalidades Urogenitais/sangue , Anormalidades Urogenitais/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA